{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T01:13:04Z","timestamp":1773277984161,"version":"3.50.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[1992,12,1]],"date-time":"1992-12-01T00:00:00Z","timestamp":723168000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[1992,12]]},"DOI":"10.1007\/bf03348807","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T11:38:08Z","timestamp":1396611488000},"page":"797-800","source":"Crossref","is-referenced-by-count":43,"title":["Recurrence of hyperthyroidism in multinodular goiter after long-term drug therapy: A comparison with Graves\u2019 disease"],"prefix":"10.1007","volume":"15","author":[{"given":"M. J. M.","family":"van Soestbergen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. C. M.","family":"van der Vijver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. D.","family":"Graafland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03348807_CR1","first-page":"360","volume":"84","author":"G Riccabona","year":"1972","unstructured":"Riccabona G., Bauer H., Mathie F., Scholz K. Zur Epidemiologie und Therapie der Hyperthyreosen in einem endemischen Kropfgebiet. Wien. Klin. Wochenschr. 84: 360, 1972.","journal-title":"Wien. Klin. Wochenschr."},{"key":"BF03348807_CR2","first-page":"550","volume":"114","author":"H Fischer","year":"1984","unstructured":"Fischer H., Morgenthaler B., Koenig M.P. Therapieresultate bei hyperthyeoten Patienten aus dem Berner Kropfendemiegebiet. Schweiz. Med. Wochenschr. 114: 550, 1984.","journal-title":"Schweiz. Med. Wochenschr."},{"key":"BF03348807_CR3","first-page":"1406","volume":"130","author":"WJ Fagel","year":"1986","unstructured":"Fagel W.J., van der Vijver J.C.M. Oorzaken van thyreotoxicosis bij 242 patienten. Ned. Tijdsch. Geneeskd. 130: 1406, 1986.","journal-title":"Ned. Tijdsch. Geneeskd."},{"key":"BF03348807_CR4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.7326\/0003-4819-100-6-891","volume":"100","author":"JT Dunn","year":"1984","unstructured":"Dunn J.T. Choice of Therapy in Young Adults with Hyperthyroidism of Graves\u2019 Disease. Ann. Intern. Med. 100: 891, 1984.","journal-title":"Ann. Intern. Med."},{"key":"BF03348807_CR5","first-page":"1637","volume":"113","author":"JA Wils","year":"1969","unstructured":"Wils J.A., Kloppenburg P.W.C. De kans op remissie van de ziekte van Graves (Basedow) na behandeling met thiouracilderivaten. Ned. Tijdsch. Geneeskd. 113: 1637, 1969.","journal-title":"Ned. Tijdsch. Geneeskd."},{"key":"BF03348807_CR6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.0954-6820.1954.tb12217.x","volume":"147","author":"G Aspenstrom","year":"1953","unstructured":"Aspenstrom G. Late results with propylthiouracil treatment of hyperthyroidism in a goiter region. Acta Med. Scand. 147: 63, 1953.","journal-title":"Acta Med. Scand."},{"key":"BF03348807_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1001\/jama.1953.03690030001001","volume":"152","author":"DH Solomon","year":"1953","unstructured":"Solomon D.H., Beck J.L., Vanderlaan W.P. Prognosis of hyperthyroidism treated by antithyroid drugs. JAMA 152: 201, 1953.","journal-title":"JAMA"},{"key":"BF03348807_CR8","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0140-6736(80)91551-2","volume":"1","author":"AM McGregor","year":"1980","unstructured":"McGregor A.M., Rees Smith B., Hall R., Petersen M.M., Miller M., Dewar P.J. Prediction of relapse in hyperthyroid Graves\u2019 disease. Lancet 1: 1101, 1980.","journal-title":"Lancet"},{"key":"BF03348807_CR9","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-60-6-982","volume":"60","author":"WS Reveno","year":"1964","unstructured":"Reveno W.S., Rosenbaum H. Observations on the use of Antithyroid Drugs. Ann. Intern. Med. 60: 982, 1964.","journal-title":"Ann. Intern. Med."},{"key":"BF03348807_CR10","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1210\/jcem-26-8-803","volume":"26","author":"JM Hershman","year":"1966","unstructured":"Hershman J.M., Givens J.R., Cassidy C.E., Astwood E.B. Longterm outcome of hyperthyroidism treated with antithyroid drugs. J. Clin. Endocrinol. Metab. 26: 803, 1966.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348807_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/acta.0.0240263","volume":"24","author":"CA Hernberg","year":"1957","unstructured":"Hernberg C.A., Lamberg B.A. Results obtained in Finland with longterm treatment of thyrotoxicosis with thyrostatic drugs. Acta Endocrinol. (Copenh.) 24: 263, 1957.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03348807_CR12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jcem-57-3-563","volume":"57","author":"JH Romaldini","year":"1983","unstructured":"Romaldini J.H., Bromberg N., Werner R.S., Tanaka L.M., Rodrigues H.F., Werner M.C., Farah C.S., Reis L.C.F. Comparison of effects of High and Low dosage regimens of antityroid drugs in the management of Graves\u2019 Hyperthyroidism. J. Clin. Endocrinol. Metab. 57: 563, 1983.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BF03348807_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1530\/acta.0.1110039","volume":"111","author":"P Laurberg","year":"1986","unstructured":"Laurberg P., Hansen P.E.B., Iversen E., Jensen S.E., Weeke J. Goiter size and outcome of medical treatment of Graves\u2019 disease. Acta Endocrinol. (Copenh.) 111: 39, 1986.","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"BF03348807_CR14","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJM199104043241403","volume":"324","author":"K Hashizume","year":"1991","unstructured":"Hashizume K., Ishikawa K., Sakurai A., Suzuki S., Takeda T., Kobayashi M., Miyamoto T., Arai M., Nagasawa T. Administration of thyroxine in treated Graves\u2019 Disease. N. Engl. J. Med. 324: 947, 1991.","journal-title":"N. Engl. J. Med."}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348807.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03348807\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03348807","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T06:32:12Z","timestamp":1565332332000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03348807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1992,12]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1992,12]]}},"alternative-id":["BF03348807"],"URL":"https:\/\/doi.org\/10.1007\/bf03348807","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[1992,12]]}}}